tiprankstipranks
Advertisement
Advertisement

ELVN Stock Latest News

Enliven price target raised to $65 from $56 at H.C. Wainwright
The FlyEnliven price target raised to $65 from $56 at H.C. Wainwright
1d ago
ELVN
Enliven price target raised to $80 from $60 at Stifel
PremiumThe Fly
Enliven price target raised to $80 from $60 at Stifel
9d ago
ELVN
Enliven price target raised to $70 from $45 at JonesResearch
PremiumThe Fly
Enliven price target raised to $70 from $45 at JonesResearch
11d ago
ELVN
Enliven Therapeutics Prices Upsized Public Equity Offering
PremiumCompany Announcements
Enliven Therapeutics Prices Upsized Public Equity Offering
28d ago
8K
ELVN
Why Is Enliven Therapeutics Stock (ELVN) Up Today?
PremiumMarket News
Why Is Enliven Therapeutics Stock (ELVN) Up Today?
28d ago
ELVN
Enliven rises 9.9%
PremiumThe FlyEnliven rises 9.9%
28d ago
ELVN
Enliven 8.9M share Spot Secondary priced at $37.50
Premium
The Fly
Enliven 8.9M share Spot Secondary priced at $37.50
28d ago
ELVN
Enliven announces $250M common stock offering
Premium
The Fly
Enliven announces $250M common stock offering
29d ago
ELVN
Midday Fly By: Oracle slides, SpaceX on deck for public debut
PremiumThe Fly
Midday Fly By: Oracle slides, SpaceX on deck for public debut
29d ago
GD
MH
Boris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
PremiumRatings
Boris Peaker Reiterates Buy Rating and $45 Price Target on ELVN-001 After Strong Phase 1b CML Data Support Best-in-Class Potential
29d ago
ELVN
Enliven rises 14.8%
PremiumThe Fly
Enliven rises 14.8%
29d ago
ELVN
Enliven advances ELVN-001 with positive Phase 1 data
PremiumCompany Announcements
Enliven advances ELVN-001 with positive Phase 1 data
29d ago
8K
ELVN
Enliven up 15% to $42.50 after positive data from Phase 1 ENABLE trial
PremiumThe FlyEnliven up 15% to $42.50 after positive data from Phase 1 ENABLE trial
29d ago
ELVN
Enliven’s ELVN-001 shows efficacy in Phase 1 myeloid leukemia trial
Premium
The Fly
Enliven’s ELVN-001 shows efficacy in Phase 1 myeloid leukemia trial
29d ago
ELVN
Enliven Therapeutics Expands Authorized Shares After Stockholder Vote
Premium
Company Announcements
Enliven Therapeutics Expands Authorized Shares After Stockholder Vote
1M ago
8K
ELVN
Toll Brothers upgraded, Lennar downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Toll Brothers upgraded, Lennar downgraded: Wall Street’s top analyst calls
1M ago
AJG
AVB
Enliven initiated with a Buy at Stifel
PremiumThe Fly
Enliven initiated with a Buy at Stifel
1M ago
ELVN
Analyst Raises Price Target to $59 and Reaffirms Buy on ELVN-001’s Differentiated CML Opportunity
PremiumRatings
Analyst Raises Price Target to $59 and Reaffirms Buy on ELVN-001’s Differentiated CML Opportunity
1M ago
ELVN
Enliven price target raised to $62 from $45 at Mizuho
PremiumThe Fly
Enliven price target raised to $62 from $45 at Mizuho
1M ago
ELVN
Boris Peaker Reiterates Buy Rating on ELVN-001 with Unchanged $45 Price Target, Citing Strong Clinical Data and Strategic Positioning
PremiumRatingsBoris Peaker Reiterates Buy Rating on ELVN-001 with Unchanged $45 Price Target, Citing Strong Clinical Data and Strategic Positioning
2M ago
ELVN
Enliven to presents Phase 1 clinical trial data for ELVN-100 at EHA Congress
Premium
The Fly
Enliven to presents Phase 1 clinical trial data for ELVN-100 at EHA Congress
2M ago
ELVN
Guggenheim starts Enliven with Buy on leukemia opportunity
Premium
The Fly
Guggenheim starts Enliven with Buy on leukemia opportunity
2M ago
ELVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >